As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...
Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...
Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback